Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
about
Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice.Reasons for compliance or noncompliance with advice to test for hepatitis C via an internet-mediated blood screening service: a qualitative study.Genotype 4 HCV infection is difficult to cure with pegylated interferon and ribavirin. Results from a Greek Nationwide Cohort Study.Significant epidemiological changes in chronic hepatitis C infection: results of the nationwide HEPNET-GREECE cohort study.Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, IranReview of models used to predict the future numbers of individuals with severe hepatitis C disease: therapeutic and cost implications.A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review.Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria.The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.S-adenosylmethionine in the chemoprevention and treatment of hepatocellular carcinoma in a rat model.Modelling the past, current and future HCV burden in France: detailed analysis and perspectives.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.Living with hepatitis C and treatment: the personal experiences of patients.
P2860
Q33816446-27E00F12-883E-4521-87B7-96ADDB23BF4AQ33898300-AD56DCDF-E800-40AD-8A49-CD00DAA42CBAQ33918559-0F2BE211-99A5-4782-94A0-8EF7054A063CQ34976736-01402A16-D268-4583-877E-41DC58243FD0Q37172311-247A8E73-94C2-4C56-A8E7-E878066DA7C2Q37763157-99AAA9F4-BAC4-48D2-B0D2-A4FAC184B3D1Q37886280-813C176B-E907-42F3-8EA8-BA2C7353D038Q38205937-4219D75A-217E-4408-AF3D-032969EE2695Q38616536-0370D033-4277-412B-991D-F50E60D7325DQ39064153-9F70625F-1117-4F69-BABB-63E6DB4557DDQ39559479-26B415D8-9DD4-41E6-816F-4D727BBDAE1CQ39851067-B0899FCF-E839-40FB-B415-AA2E1CDB02BBQ40024651-0D3EDBA5-815A-48A6-87C2-C6D20B43E35FQ42382462-90DB16BA-7933-4459-9BD0-D441AD82F95BQ49140465-A539DE6A-28EA-4A2C-85F2-2BAFD919F6C4
P2860
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Future trends of HCV-related c ...... urrently available treatments.
@en
type
label
Future trends of HCV-related c ...... urrently available treatments.
@en
prefLabel
Future trends of HCV-related c ...... urrently available treatments.
@en
P2093
P2860
P1476
Future trends of HCV-related c ...... urrently available treatments.
@en
P2093
A Hatzakis
D Tsantoulas
E Akriviadis
G Touloumi
G V Papatheodoridis
I Ketikoglou
I Vafiadis
N C Tassopoulos
S Koutsounas
P2860
P304
P356
10.1111/J.1365-2893.2005.00588.X
P577
2005-09-01T00:00:00Z